SARS-CoV-2-infection in the setting of autotransplants for multiple sclerosis
ABSTRACTThe severe adult respiratory syndrome virus type 2 (SARS-CoV-2) related acute respiratory distress syndrome (ARDS) has a strong immunological and inflammatory component; accordingly investigators are employing monoclonal antibodies to ameliorate the virus-induced cytokine storm such as antib...
Main Authors: | Juan Carlos Olivares-Gazca, Robert Peter Gale, Daniela Sánchez-Bonilla, Moisés Manuel Gallardo-Pérez, Silvia Soto-Olvera, Guillermo J. Ruiz-Delgado, Guillermo José Ruiz-Argüelles |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2023-12-01
|
Series: | Hematology |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/16078454.2022.2164443 |
Similar Items
-
CLINICAL EFFECTIVENESS OF HIGH-DOSE IMMUNOSUPPRESSIVE THERAPY WITH AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN MULTIPLE SCLEROSIS PATIENTS
by: D. A. Fedorenko, et al.
Published: (2014-12-01) -
Dynamics of Inflammatory and Neurodegenerative Biomarkers after Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis
by: Josefine Ruder, et al.
Published: (2022-09-01) -
Rituximab as a Treatment Option after Autologous Hematopoietic Stem Cell Transplantation in a Patient with Systemic Sclerosis
by: Paul Gressenberger, et al.
Published: (2021-06-01) -
Patients with systemic sclerosis and low CD4 numbers after autologous stem cell transplantation have a favorable outcome
by: Ann-Christin Pecher, et al.
Published: (2024-03-01) -
Immunoablative therapy followed by autologous hematopoietic stem cell transplantation as the first-line disease-modifying therapy in patients with multiple sclerosis
by: Martin Lachnit, et al.
Published: (2024-03-01)